BBSW 2020 Virtual Syposiums Series
Embracing Challenges and Opportunities Posed by the COVID-19 Pandemic
A Showcase of Pragmatic Examples by Clinical Trial Statisticians
Thursday August 13 8:30 am-11:30 am PT: Evaluating COVID-19 impact on ongoing studies
- Keynote speaker: Robert Califf, Head of Clinical Policy and Strategy for Verily and Google, former FDA Commissioner
- Efficacy analyses for trials impacted by COVID-19 (Marcel Wolbers, Chin-Yu Lin, Zoe Zhang, Xin Li, Roche/Genentech)
- Tools to assess the impact of COVID-19 on data integrity and interpretation (Chin-Yu Lin and Zoe Zhang, Roche/Genentech)
Friday August 14 8:30 am-11:30 am PT: Examples of impact on safety and efficacy
- Considerations and practices in monitoring COVID-19 impact (Priscilla Yen, Amgen)
- Safety assessment for studies and submissions impacted by COVID-19 (Greg Ball, Merck)
- Summaries of COVID-19 infections in clinical trials (Mary Nilsson, Lilly)
- Round table: How pharma/biotech navigates COVID-19 and what roles statisticians play during the crisis
Tickets for the virtual symposiums can be purchased separately for either date or for both dates at a discount.
Raffle drawings will be held at the beginning and end of each day's session!
More information about the BBSW can be found here.